zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
astator
krka, d.d., novo mesto - atorvastatinas - plėvele dengtos tabletės - 80 mg; 60 mg; 30 mg - atorvastatin
atoris
krka, d.d., novo mesto - atorvastatinas - plėvele dengtos tabletės - 80 mg; 60 mg; 30 mg; 40 mg; 20 mg; 10 mg - atorvastatin
atorvastatin accord
accord healthcare b.v. - atorvastatinas - plėvele dengtos tabletės - 40 mg; 10 mg; 20 mg - atorvastatin
atorvastatin actavis
actavis group ptc ehf. - atorvastatinas - plėvele dengtos tabletės - 80 mg; 20 mg; 10 mg; 40 mg - atorvastatin
atorvastatin zentiva
zentiva k.s. - atorvastatinas - plėvele dengtos tabletės - 80 mg; 10 mg; 20 mg - atorvastatin
sortis
upjohn eesv - atorvastatinas - plėvele dengtos tabletės - 20 mg; 10 mg; 80 mg; 40 mg - atorvastatin
sortis
upjohn eesv - atorvastatinas - kramtomosios tabletės - 40 mg; 20 mg; 10 mg; 5 mg - atorvastatin
torvacard
zentiva k.s. - atorvastatinas - plėvele dengtos tabletės - 10 mg; 20 mg - atorvastatin
torzelip
zentiva k.s. - ezetimibas/atorvastatinas - tabletės - 10 mg/10 mg - atorvastatin and ezetimibe